Test Price
650 AED✅ Home Collection Available
Cardiometabolic Syndrome Panel Advanced Test in UAE | 650 AED | DHA Licensed
Executive Summary & Core Metrics
The Cardiometabolic Syndrome Panel provides a comprehensive, multi-marker evaluation integrating next-generation sequencing (NGS) with IFCC-standardized biochemical assays. It offers 99.9% diagnostic sensitivity through ISO-certified processing and enables early detection of metabolic and cardiovascular imbalances. Logistics include VIP mobile phlebotomy with temperature-controlled cold-chain home collection (daily 8 AM–11 PM), same-day reporting for samples received by 2 PM, and complimentary post-test telephonic consultation by a DHA-licensed physician. Insurance verification is available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced panel surpasses routine blood work by using NGS for genetic risk scoring and IFCC-standardized methods (hexokinase, BCG, biuret, immunoturbidimetry, HPLC) to quantify over 20 precision biomarkers, including comprehensive lipid subfractions, NGSP-certified HbA1c, and novel inflammatory markers. It guides personalized prevention and treatment strategies for patients at risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision & Methodology | NGS + IFCC Standardized + Hexokinase/BCG/Biuret/Immunoturbidimetry + HPLC | Standard photometric/enzymatic only |
| Clinical Depth | Genetic risk scores, novel biomarkers (NGSP-certified HbA1c), comprehensive lipid subfractions | Basic lipid profile and glucose |
| Turnaround Time | Same-day reporting (sample by 2 pm) | 1–3 days |
Physician Insight & Safety Protocols
“This comprehensive panel provides valuable insight into early metabolic dysregulation. However, results must always be interpreted within the full clinical context, including age, weight, comorbidities, and medication history. It does not replace a detailed clinical evaluation or imaging. Always correlate findings with symptoms and consult your treating physician before making any treatment decisions.” — Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)
Medication Advisory
Do not discontinue any prescribed medications, especially antihypertensives, insulin, or oral hypoglycemics, without explicit consultation with your treating physician. Abrupt cessation may precipitate a hypertensive crisis, severe hyperglycemia, or other adverse events. This panel requires overnight fasting, but all medications should be taken as usual unless otherwise directed.
Safety Exclusion Criteria
- Acute febrile illness or recent surgery (within 4 weeks)
- Known active bleeding disorders or anticoagulant therapy that cannot be safely paused for venipuncture
- Severe needle phobia with history of vasovagal syncope without physician clearance
Emergency Red Flags (seek immediate care)
- New‑onset crushing chest pain, severe shortness of breath, or palpitations
- Extreme hypertension (systolic BP >200 mmHg) or symptomatic hypotension
- Acute confusion, loss of consciousness, or signs of stroke
Patient FAQ & Clinical Guidance
1. What does the Cardiometabolic Syndrome Panel measure and how does it differ from routine blood work?
This panel quantifies over 20 precision biomarkers using NGS and IFCC-standardized methods, providing genetic risk scoring and advanced lipid subtyping that routine tests cannot detect. It enables early intervention for metabolic syndrome, type 2 diabetes, and cardiovascular disease.
2. I am on statins and metformin—should I stop them before the test?
Never discontinue any prescribed medication without your doctor’s approval. This panel requires overnight fasting but all medications should be taken as usual unless otherwise directed by your physician.
3. How quickly will I get my results and can a doctor explain them?
Results are delivered the same day if your sample reaches the lab by 2 PM. A complimentary post-test telephonic consultation with a DHA-licensed physician is provided to clarify all findings and guide next steps.
UAE Regulatory & Data Privacy Adherence
All patient data is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your health information is encrypted, access-controlled, and never shared without prior authorization.
Clinical & Logistical Metadata
| Test Name | Cardiometabolic Syndrome Panel Advanced Test |
| Price (AED) | 650 |
| Turnaround Time | Same-day if sample received by 2 PM |
| Sample Type / Matrix | Peripheral whole blood (serum/plasma) |
| Methodology Used | NGS, IFCC-Standardized Biochemistry (Hexokinase, BCG, Biuret, Immunoturbidimetry, HPLC) |
| ICD-10-CM Code | E88.81 |
| LOINC Code | 54089-8 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians